APM
Avidity Partners Management’s Syndax Pharmaceuticals SNDX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.4M | Sell |
150,000
-775,000
| -84% | -$7.26M | 0.28% | 50 |
|
|
2025
Q1 | $11.4M | Sell |
925,000
-575,000
| -38% | -$7.06M | 2.17% | 13 |
|
|
2024
Q4 | $19.8M | Sell |
1,500,000
-955,000
| -39% | -$12.6M | 1.95% | 21 |
|
|
2024
Q3 | $47.3M | Sell |
2,455,000
-880,000
| -26% | -$16.9M | 2.41% | 10 |
|
|
2024
Q2 | $68.5M | Buy |
3,335,000
+922,500
| +38% | +$18.9M | 2.91% | 7 |
|
|
2024
Q1 | $57.4M | Sell |
2,412,500
-1,537,500
| -39% | -$36.6M | 1.85% | 18 |
|
|
2023
Q4 | $85.4M | Buy |
3,950,000
+1,129,000
| +40% | +$24.4M | 3.11% | 6 |
|
|
2023
Q3 | $41M | Sell |
2,821,000
-51,000
| -2% | -$741K | 1.65% | 23 |
|
|
2023
Q2 | $60.1M | Sell |
2,872,000
-993,300
| -26% | -$20.8M | 2.1% | 14 |
|
|
2023
Q1 | $81.6M | Sell |
3,865,300
-1,995,700
| -34% | -$42.1M | 2.71% | 13 |
|
|
2022
Q4 | $149M | Buy |
5,861,000
+274,100
| +5% | +$6.98M | 3.23% | 8 |
|
|
2022
Q3 | $134M | Buy |
5,586,900
+136,900
| +3% | +$3.29M | 2.73% | 8 |
|
|
2022
Q2 | $105M | Buy |
5,450,000
+626,600
| +13% | +$12.1M | 2.41% | 17 |
|
|
2022
Q1 | $83.8M | Hold |
4,823,400
| – | – | 1.75% | 21 |
|
|
2021
Q4 | $106M | Hold |
4,823,400
| – | – | 2.24% | 18 |
|
|
2021
Q3 | $92.2M | Buy |
4,823,400
+208,400
| +5% | +$3.98M | 2.04% | 8 |
|
|
2021
Q2 | $79.2M | Buy |
4,615,000
+769,000
| +20% | +$13.2M | 2.14% | 12 |
|
|
2021
Q1 | $86M | Buy |
3,846,000
+538,000
| +16% | +$12M | 2.38% | 9 |
|
|
2020
Q4 | $73.6M | Buy |
3,308,000
+1,453,900
| +78% | +$32.3M | 2.39% | 12 |
|
|
2020
Q3 | $27.4M | Buy |
1,854,100
+326,700
| +21% | +$4.82M | 1.27% | 23 |
|
|
2020
Q2 | $22.6M | Buy |
+1,527,400
| New | +$22.6M | 1.45% | 24 |
|